The analyst was referring to the downward movement on the graphs for RSBQ and CGI, with a downward movement corresponding with an improvement in symptoms. As the trend lines were still going downward at the point when the study stopped, one might extrapolate that there would have been further improvement on both measures had the study been longer.
Phase 2 trial - increasing or decreasing when it stopped?????, page-2
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.76 |
Change
-0.210(1.05%) |
Mkt cap ! $2.523B | |||
| Open | High | Low | Value | Volume |
| $19.96 | $19.96 | $19.69 | $2.229M | 112.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 50 | $19.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.77 | 229 | 3 |
View Market Depth
| Last trade - 13.47pm 05/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |